Julie Earl
Bayer (United States)(US)Instituto Cajal(ES)Trinity College of Florida(US)Instituto Ramón y Cajal de Investigación Sanitaria(ES)Parc de Salut(ES)Health Economics and Outcomes Research (United Kingdom)(GB)Centro de Investigación Biomédica en Red de Cáncer(ES)Hospital Universitario Ramón y Cajal(ES)Medical Research Network(US)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Ethics in Clinical Research, Cancer-related molecular mechanisms research, Neuroendocrine Tumor Research Advances
Most-Cited Works
- → Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers(2016)333 cited
- → Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy(2013)289 cited
- → Mosaic loss of chromosome Y is associated with common variation near TCL1A(2016)230 cited
- → Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer(2015)176 cited
- → Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)(2015)155 cited
- → ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity(2020)135 cited